GlassScriptPhysician profile
Cody J Gibbs
NPI 1205335510
$6,436.96
in general payments reported to CMS, 2019-2025
35 companies · $1,627 in 2025
The $1,627 reported for 2025 was more than what 91% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $582 · 2022: $1,191 · 2023: $1,305 · 2024: $1,732 · 2025: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,644 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,644.03 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $888.47 | 2021-2025 | |
| Supernus Pharmaceuticals, INC. | $588.90 | 2022-2025 | Qelbree, Qelbree |
| Novartis Pharmaceuticals Corporation | $549.62 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.79 | 2021-2025 | Jardiance |
| Pfizer INC. | $362.49 | 2021-2025 | |
| Amgen INC. | $338.58 | 2021-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $333.68 | 2021-2025 | |
| Abbott Laboratories | $322.98 | 2021-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Lilly USA, LLC | $319.49 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Aimmune Therapeutics, INC. | $305.27 | 2024-2025 | Zenpep, Vowst |
| Dexcom, INC. | $249.71 | 2021-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $217.54 | 2023-2025 | Caplyta |
| Glaxosmithkline, LLC. | $211.57 | 2021-2023 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $184.32 | 2022 | |
| Novo Nordisk INC | $171.41 | 2021-2025 | Wegovy, Ozempic |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $153.35 | 2021-2025 | Farxiga, Breztri |
| Otsuka America Pharmaceutical, INC. | $100.61 | 2023-2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $98.67 | 2022-2025 | Eliquis, Cobenfy, Camzyos |
| Harmony Biosciences LLC | $79.39 | 2023-2025 | Wakix |
| Biohaven Pharmaceuticals, INC. | $78.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.79 | 2022-2023 | Gattex |
| Lundbeck LLC | $57.85 | 2024-2025 | Vyepti |
| Mylan Specialty L.P. | $56.11 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $48.81 | 2025 | Voquezna |
| Eisai INC. | $34.74 | 2021 | |
| Boston Scientific Corporation | $32.93 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $29.47 | 2025 | |
| Nestle Healthcare Nutrition INC. | $27.74 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $25.97 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $23.15 | 2023 | Intellis Adaptivestim |
| Exact Sciences Corporation | $22.12 | 2023 | Cologuard Collection Kit |
| Almatica Pharma LLC | $18.02 | 2023 | Loreev Xr |
| Sanofi-Aventis U.S. LLC | $17.75 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $17.50 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $16.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Gibbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.